Get Premium to unlock powerful stock data
NAS:BEAM (USA)  
Beam Therapeutics Inc logo

Beam Therapeutics Inc

$ 40.40 -2.69 (-6.24%) 08:08 PM EST
P/E:
At Loss
P/B:
3.64
Market Cap:
$ 2.84B
Enterprise V:
$ 1.96B
Volume:
1.14M
Avg Vol (2M):
1.48M
Volume:
1.14M
Market Cap $:
2.84B
PE Ratio:
At Loss
Avg Vol (2-Month):
1.48M
Enterprise Value $:
1.96B
PB Ratio:
3.64
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Beam Therapeutics Inc
NAICS : 325411 SIC : 2833
238 Main Street, 9th Floor, Cambridge, MA, USA, 02142
Description
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing.
Name Current Vs Industry Vs History
Cash-To-Debt 8.14
Equity-to-Asset 0.57
Debt-to-Equity 0.18
Debt-to-EBITDA -0.58
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.45
Distress
Grey
Safe
Beneish M-Score 2235.14
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 85.41
9-Day RSI 71.7
14-Day RSI 63
6-1 Month Momentum % -54.05
12-1 Month Momentum % -66.86

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.66
Quick Ratio 5.66
Cash Ratio 5.59
Days Sales Outstanding 1059.81

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -24.9

Financials (Next Earnings Date:2022-08-10 Est.)

BEAM's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:BEAM

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 60.27
EPS (TTM) ($) -3.61
Beta 0
Volatility % 94.28
14-Day RSI 63
14-Day ATR ($) 3.632718
20-Day SMA ($) 36.47825
12-1 Month Momentum % -66.86
52-Week Range ($) 27.77 - 138.5219
Shares Outstanding (Mil) 70.27

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Beam Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More